≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback
info icon

This is a non-core endpoint: only basic statistics are computed.

See these related core endpoints for full statistics:

Other effects of reduced temperature

Endpoint Browser

ST19_OTHER_EFFEC_REDUCED_TEMPE

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — T69
  • Cause of death: ICD-10 — T69

2 out of 7 registries used, show all original rules.

77

4. Check minimum number of events

None

77

5. Include endpoints

None

77

6. Filter based on genotype QC (FinnGen only)

77

Control definitions (FinnGen only)

Control exclude
ST19_OTHER_UNSPE_EFFEC_EXTER_CAUSES

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF4
Parent code in ICD-10
T6[6-9]|T7[0-8]
Name in latin
Alii effectus caloris deminuti

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

All Female Male
Number of individuals 77 43 34
Unadjusted period prevalence (%) 0.01 0.01 0.01
Median age at first event (years) 47.33 42.77 53.11

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
67
Matched controls
669
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
T69.1
ICD-10 Finland
Chilblains
+∞
28.1
25
*
T69.8
ICD-10 Finland
Other specified effects of reduced temperature
+∞
23.3
21
*
T69.9
ICD-10 Finland
Effect of reduced temperature, unspecified
+∞
12.9
12
*
T69.0
ICD-10 Finland
Immersion hand and foot
+∞
9.6
9
*
X31
ICD-10 Finland
Exposure to excessive natural cold
+∞
8.5
8
*
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
6.9
7.5
19
36
C03CA01
ATC
furosemide; systemic
4.4
6.5
26
84
M48.0
ICD-10 Finland
Spinal stenosis
6.7
6.4
16
30

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3037522) Nuclear Ab [Titer] in Serum
29
85
4.87
9.67
2.2
1.3
titre
748.0
566.7
—
10
18
(42870588) Differential panel, method unspecified - Blood
43
195
3.73
7.54
8.8
5.5
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
12
20
6.92
7.14
2.4
2.0
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
54
302
3.64
6.51
7.5
6.0
e9/l
0.0
0.0
0.88
48
267
(40768443) Skin Pathology biopsy report
10
15
7.51
6.48
1.4
1.2
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
23
75
3.95
6.42
1.9
1.5
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
55
315
3.61
6.30
8.8
6.2
e9/l
0.2
0.2
0.18
48
282
(3004588) Protein electrophoresis panel - Serum or Plasma
16
40
4.79
6.26
1.4
2.0
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
54
307
3.54
6.24
6.6
6.0
e9/l
1.8
1.8
0.08
49
279
(3001604) Monocytes [#/volume] in Blood
53
301
3.44
6.07
6.8
6.0
e9/l
0.6
0.6
0.84
47
267
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
27
107
3.35
5.56
1.4
1.2
iu/ml
18.8
26.8
0.34
11
39
(3013650) Neutrophils [#/volume] in Blood by Automated count
57
359
3.26
5.10
9.0
10.5
e9/l
4.5
4.1
0.57
51
315
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
25
110
2.88
4.18
2.1
1.6
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
7
8
9.47
3.86
1.3
1.1
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
27
132
2.61
3.64
1.4
1.4
g/l
2.4
2.3
0.23
21
80
(3037467) Urinalysis macro (dipstick) panel - Urine
58
417
2.58
3.25
6.7
4.3
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
26
133
2.44
3.14
2.0
2.8
—
—
—
0
0
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
8
16
5.44
3.14
1.1
1.1
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
6
8
8.01
3.11
1.0
1.3
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
7
12
6.29
3.09
1.4
1.0
—
—
—
0
0
(3023420) DNA double strand Ab [Units/volume] in Serum
5
5
10.56
3.02
1.8
1.2
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
40
251
2.24
2.99
6.8
8.7
mmol/l
1.2
1.2
0.10
33
220
(3021879) Hepatitis B virus core Ab [Presence] in Serum
13
47
3.12
2.99
1.5
1.4
—
—
—
0
0
(3015736) pH of Urine
37
225
2.24
2.98
4.2
3.5
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
36
217
2.24
2.96
2.2
1.9
pmol/l
95.8
97.1
0.06
21
103
(3042936) Bacteria identified in Isolate by Culture
19
87
2.57
2.86
2.1
2.5
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
13
49
2.99
2.79
1.7
1.9
g/l
66.5
66.5
0.00
13
42
(3013512) EKG study
29
167
2.18
2.61
5.7
4.0
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
40
263
2.08
2.54
11.8
9.5
e9/l
0.0
0.0
0.00
35
217
(3007853) Bacteria identified in Skin by Aerobe culture
17
78
2.51
2.54
3.2
1.6
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
20
100
2.35
2.49
1.5
1.3
u/ml
31.1
13.3
—
7
44
(46235355) HIV 1 and 2 tests - Meaningful Use set
25
138
2.20
2.48
2.3
1.9
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
14
59
2.68
2.46
1.3
1.9
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
30
179
2.11
2.44
2.4
2.8
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
42
285
2.04
2.41
4.8
4.9
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
25
140
2.16
2.38
1.2
1.2
u/ml
0.6
0.6
—
8
34
(3018095) Leukocytes [#/volume] in Urine
34
216
2.03
2.32
4.0
3.4
e6/l
19.6
85.1
0.73
27
155
(3021960) Folate [Moles/volume] in Serum or Plasma
24
135
2.13
2.25
1.8
1.5
nmol/l
20.0
19.8
0.02
19
114
(3037756) Immunofixation for Serum or Plasma
5
9
5.85
2.25
1.4
1.8
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
68
576
2.54
2.13
4.5
4.6
mu/l
1.9
1.9
0.08
61
511
(40758558) Short blood count panel - Blood
23
132
2.06
2.03
5.1
7.4
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
32
207
1.93
2.02
5.0
2.8
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
9
33
2.95
2.01
2.9
1.2
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
6
16
3.97
1.97
1.3
1.4
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
13
59
2.45
1.97
1.5
2.0
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
9
34
2.86
1.94
2.9
1.2
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
9
34
2.86
1.94
3.0
1.2
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
9
34
2.86
1.94
2.9
1.2
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
39
273
1.87
1.92
8.1
10.5
mmol/l
1.2
1.2
0.11
30
226
(3032080) INR in Blood by Coagulation assay
33
219
1.89
1.92
9.4
8.0
inr
1.1
1.2
—
8
75
(3031040) Bacteria [#/volume] in Urine by Automated count
53
411
1.93
1.88
5.5
3.9
—
74.4
—
0
7
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
5
12
4.37
1.85
3.2
1.1
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
8
29
2.96
1.85
1.1
2.0
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
34
231
1.84
1.82
4.2
3.4
ng/l
29.7
33.7
0.10
25
151
(40761535) Cells panel - Urine sediment
10
42
2.59
1.76
5.2
2.8
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
42
309
1.79
1.70
7.5
5.0
estimate
0.0
0.0
—
8
63
(3013139) Helicobacter pylori Ag [Presence] in Stool
8
32
2.67
1.65
1.3
1.1
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
42
311
1.77
1.65
5.6
3.6
estimate
0.0
0.0
—
8
65
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
5
14
3.74
1.64
2.8
1.6
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
25
159
1.85
1.62
4.2
3.2
ng/l
1976.3
1570.6
0.19
19
132
(3033658) Prothrombin time (PT) actual/Normal
22
135
1.88
1.58
3.5
3.4
%
92.8
90.7
0.13
22
135
(3011397) Hemoglobin [Presence] in Urine by Test strip
22
135
1.88
1.58
3.9
3.5
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
5
15
3.49
1.55
1.8
1.7
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
5
15
3.49
1.55
1.8
1.7
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
5
15
3.49
1.55
1.8
1.7
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
5
15
3.49
1.55
1.8
1.7
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
22
137
1.85
1.51
1.9
1.8
mg/l
0.9
1.2
0.35
17
106
(3009261) Glucose [Presence] in Urine by Test strip
42
318
1.71
1.47
5.5
3.7
estimate
0.0
0.0
—
8
63
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
5
16
3.27
1.46
1.8
1.7
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
5
16
3.27
1.46
1.8
1.3
—
—
—
0
0
(3019060) Gas panel - Arterial blood
9
41
2.35
1.42
4.9
16.5
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
22
140
1.80
1.40
6.3
4.5
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
5
17
3.07
1.38
1.0
1.5
—
—
—
0
0
(3026782) Osmolality of Urine
19
116
1.85
1.38
3.6
2.6
mosm/kgh2o
531.3
533.1
0.01
19
95
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
21
133
1.80
1.36
1.2
1.7
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
6
24
2.62
1.33
1.7
1.4
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
5
18
2.90
1.30
1.2
1.2
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
56
467
1.73
1.30
3.7
4.0
pmol/l
14.6
14.8
0.24
48
413
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
8
38
2.23
1.22
4.4
2.3
ng/l
216.5
124.8
—
8
33
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
8
39
2.17
1.19
1.6
1.8
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
7
30
2.46
1.16
3.9
3.8
mmol/l
25.5
24.5
—
7
30
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
7
31
2.38
1.13
1.9
1.6
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
7
32
2.30
1.11
3.4
1.2
—
—
—
0
0
(4010399)
9
51
1.86
0.98
1.4
1.5
—
—
—
0
0
(3019225) pH of Specimen
10
55
1.94
0.97
6.1
6.1
—
—
—
0
0
(3000492) Spirometry study
9
52
1.83
0.96
1.2
1.3
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
12
71
1.82
0.95
1.0
1.5
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
23
164
1.57
0.95
6.8
4.7
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
6
28
2.24
0.94
2.5
2.2
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
72
672
2.10
0.85
23.3
12.9
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
22
162
1.50
0.78
3.5
2.6
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
5
24
2.16
0.76
1.8
1.3
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
5
24
2.16
0.76
2.8
1.2
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
65
593
1.62
0.75
4.7
4.3
mmol/l
5.7
5.9
0.43
60
531
(3044889) 12 lead EKG panel
34
407
0.71
0.74
4.9
3.7
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
5
26
1.99
0.72
1.8
1.7
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
5
26
1.99
0.72
3.2
1.5
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
13
86
1.62
0.71
1.8
1.5
—
—
—
0
0
(1002224) Polysomnography panel
5
28
1.84
0.67
1.0
1.1
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
23
180
1.40
0.59
6.2
3.6
estimate
0.0
0.0
—
8
61
(3012544) pH of Venous blood
10
65
1.62
0.59
7.0
4.4
—
—
—
0
0
(3018418) pH of Serum or Plasma
22
171
1.40
0.59
5.8
4.3
ph
7.4
7.4
—
7
32
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
9
64
1.46
0.54
2.1
1.3
—
—
—
0
0
(3022145) Colonoscopy Study observation
9
64
1.46
0.54
1.4
1.3
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
23
183
1.37
0.53
5.7
3.3
mmol/l
8.3
8.0
0.12
18
149
(36660697) Celiac disease serology panel - Serum
7
48
1.50
0.48
1.4
1.1
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
63
587
1.40
0.48
20.2
12.6
ml/min/173m2
83.2
85.2
0.23
57
468
(3019832) Treponema pallidum Ab [Presence] in Serum
10
70
1.49
0.44
1.7
1.8
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
5
31
1.65
0.44
7.2
27.9
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
8
57
1.45
0.44
8.0
3.7
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
0
16
0.00
0.41
0.0
4.6
—
37.4
—
0
10
(40768793) Breast Pathology biopsy report
0
17
0.00
0.41
0.0
1.3
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
0
18
0.00
0.40
0.0
1.4
—
—
—
0
0
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
5
35
1.46
0.40
4.2
4.3
%
70.6
52.2
—
5
35
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
0
19
0.00
0.39
0.0
1.6
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
5
76
0.63
0.38
2.0
1.3
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
19
229
0.77
0.37
2.1
2.9
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
62
586
1.30
0.33
23.1
14.2
%
40.0
40.3
0.08
42
440
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
7
51
1.41
0.32
2.4
5.0
mmol/l
1.2
1.2
—
7
43
(3000991) Gas panel - Venous blood
7
51
1.41
0.32
8.3
9.4
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
21
177
1.26
0.32
1.6
1.4
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
8
63
1.30
0.29
2.3
1.3
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
13
105
1.29
0.27
1.4
1.3
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
5
37
1.38
0.24
4.6
2.5
%
2.2
1.3
—
5
37
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
3.7
—
3.2
—
0
12
(3002523) Influenza virus A Ag [Presence] in Specimen
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
28
253
1.17
0.21
6.6
3.7
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
0
13
0.00
0.21
0.0
1.7
—
2.9
—
0
5
(3012516) Albumin [Mass/volume] in Urine
19
166
1.19
0.20
5.8
3.5
mg/l
168.4
77.6
0.38
14
106
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
0
14
0.00
0.20
0.0
2.3
—
117.6
—
0
8
(3039443) Prostate specific Ag panel - Serum or Plasma
0
14
0.00
0.20
0.0
1.6
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
20
177
1.18
0.19
6.6
4.3
mg/mmol
5.7
13.1
0.93
14
112
(3002256) Pathology report gross observation
8
67
1.22
0.17
1.1
1.2
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
59
611
0.85
0.17
4.9
4.3
mmol/l
1.5
1.4
0.29
54
556
(40768797) Stomach Pathology biopsy report
10
83
1.24
0.16
1.4
1.2
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
10
117
0.83
0.14
3.7
2.7
ug/l
0.5
0.8
—
10
70
(3004119) Hemoglobin [Mass/volume] in Venous blood
5
43
1.17
0.10
5.6
4.7
g/l
138.0
129.3
—
5
43
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
6
56
1.08
0.09
12.0
3.2
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
5
64
0.77
0.08
1.6
1.9
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
9
99
0.90
0.07
1.4
2.4
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
44
450
0.95
0.04
3.0
3.1
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
18
188
0.94
0.02
7.4
3.3
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
25
242
1.05
0.02
2.4
1.8
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
16
154
1.05
0.00
4.2
4.3
%
18.3
23.4
—
9
65
(3026008) Bacteria identified in Urine by Culture
20
196
1.03
0.00
4.6
2.9
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
0
8
0.00
0.00
0.0
2.4
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
0
8
0.00
0.00
0.0
3.5
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3020717) Zinc [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.6
—
18.5
—
0
8
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.0
—
323.7
—
0
7
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(4281824)
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
7
74
0.94
0.00
7.0
7.2
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
3.6
—
877.0
—
0
5
(3017315) Amylase [Enzymatic activity/volume] in Urine
0
5
0.00
0.00
0.0
1.4
—
114.4
—
0
5
(3051593) INR in Capillary blood by Coagulation assay
0
5
0.00
0.00
0.0
13.8
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3011648) Oxygen content in Venous blood
0
6
0.00
0.00
0.0
3.0
—
11.1
—
0
6
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
2.2
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
0
7
0.00
0.00
0.0
1.9
—
—
—
0
0
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
0
5
0.00
0.00
0.0
1.0
—
6.6
—
0
5
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(4211845)
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3010838) Calcium [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3026470) Cobalt [Mass/volume] in Blood
0
5
0.00
0.00
0.0
2.2
—
4.0
—
0
5
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
3.7
—
61.7
—
0
6
(4146454)
0
7
0.00
0.00
0.0
3.9
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
2.2
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
9
92
0.98
0.00
1.4
2.2
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
2.2
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
0
9
0.00
-0.00
0.0
3.4
—
20.2
—
0
9
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
0
9
0.00
-0.00
0.0
1.9
—
2.2
—
0
9
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
0
9
0.00
-0.00
0.0
6.1
—
194.2
—
0
9

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: ST19_OTHER_EFFEC_REDUCED_TEMPE – Other effects of reduced temperature

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).